X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Guest Post: Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey

By Guest Contributor  |    July 24, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

New PhRMA resources chock full of biopharma industry facts

By John Corea  |    July 20, 2017
Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for...   Read More

New medicines are part of the solution to hold down future health care costs

By Amey Sutkowski  |    June 28, 2017
Innovative medicines improve patient outcomes and can yield significant economic savings. The introduction of a medicine by 2020 that delays the onset of Alzheimer’s disease by just five years...   Read More

New report highlights impact of intellectual property on U.S. economy

By Mark Grayson  |    October 13, 2016
In late September, the U.S. Department of Commerce released a comprehensive report that found intellectual property (IP) intensive industries contribute more than $6 trillion (38.2 percent) to...   Read More

Nearly 4.5 million jobs and counting

By Priscilla VanderVeer  |    May 17, 2016
At PhRMA, we have the honor of highlighting the hope that America’s biopharmaceutical companies bring to patients in the form of innovative treatments and cures. But beyond the value that...   Read More

PhRMA member companies invested $58.8 billion in R&D in 2015

By Stephen J. Ubl  |    May 12, 2016
For more than 30 years, the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, driving innovation for patients. And PhRMA member companies continue to...   Read More

A new kind of Chart Pack

By Christian Clymer  |    October 15, 2015
I’m excited to introduce our new online Chart Pack, a resource designed to visually demonstrate how much value America’s biopharmaceutical researchers and manufacturers bring to our nation’s...   Read More

From Hope to Cures: The Value of Biopharmaceutical Innovation

By Ieva M. Augstums  |    August 20, 2015
Biopharmaceutical innovation means more than helping patients lead longer, healthier, more productive lives. Through the continued development of new treatments and cures, each discovery...   Read More

Biopharmaceutical Innovation Benefits Many Sectors of Industry

By PhRMA Staff  |    July 8, 2015
While the connection between sectors isn’t obvious to many, the sheet metal industry plays an integral role in the development of new medicines. Without it, many innovative new treatment options...   Read More

PhRMA Member Companies Invested $51.2 Billion in R&D in 2014

By John Castellani  |    April 20, 2015
Earlier today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced that its member companies have invested more than $600 billion in the search for new treatments and cures...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates